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Complete DNA sequences of the small subunit riboso-
mal RNA (SSUrRNA) gene and partial sequences of three
other loci were obtained from three variant-type and three
classic-type  Plasmodium ovale isolates from Southeast
Asia and compared with GenBank-available data. Three
different  SSUrRNA sequences (Pov 1–3) were found in
each variant-type isolate, and two different SSUrRNA
sequences (Poc 1–2) in each classic-type isolate. Pov 1–3
were closer to sequences previously found in the
Cameroon and MAL/MAI isolates, whereas Poc 1–2 were
closer to sequences previously found in two clones of the
Nigerian I/CDC strain. The 3' half of Pov 1–3 was identical
to the partial sequence of the SSUrRNA gene from the
London School (LS) strain. Results support grouping P.
ovale into two groups, the classic type (including the
Nigerian I/CDC strain) and the variant type (Cameroon,
MAL/MAI, and LS isolates).
T
he geographic range of the human malaria parasite
Plasmodium ovale has been thought to be mostly lim-
ited to tropical Africa, the Middle East, Papua New Guinea,
and Irian Jaya in Indonesia; it has rarely been described in
other countries of Southeast Asia. More recently, however,
with the aid of polymerase chain reaction (PCR)-based
species identification and improved microscopic tech-
niques, P. ovale infections have been frequently reported in
Southeast Asia (1,2). P. ovale may represent an emerging
cause of benign and relapsing tertian malaria in this region
or, alternatively, may have been overlooked in previous sur-
veys based on classic microscopy techniques (1). The wide-
spread distribution of P. ovale in Southeast Asia affects the
choice of appropriate drugs for malaria chemoprophylaxis
in travelers, since most currently used regimens are not
effective against the dormant liver stages of P. ovale and P.
vivax, which may cause relapses several months after the
primary infection (3).
During our previous molecular studies of P. ovale in
southern Vietnam (4), we found two field isolates whose
partial sequences at the block 9 region (5) of the small sub-
unit ribosomal RNA (SSUrRNA) genes had a deletion of 2
nt (G-G) and a substitution of 1 nt (C to T), when com-
pared with the classic type, the Nigerian I/CDC strain (6).
These polymorphisms had practical implications, since
they occurred in the target of a diagnostic oligonucleotide
probe used by the commercially available microtiter-plate
hybridization (MPH) method for malaria diagnosis (4).
Soon after, the same sequence variation was reported in
three cases imported from Africa into Japan (7); all
patients had single infections with the variant P. ovale.
Later, variant-type sequences were found in the Cameroon
(8) and MAL/MAI isolates (L.K. Basco, unpub. data), as
well as in isolates from other Southeast Asian countries
such as Thailand, Laos, Myanmar, and Indonesia (9–12).
Four features of sequence variation in P. ovale soon
became clear: 1) both classic and variant-type parasites
occurred in sympatry (i.e., they co-occurred in the same
disease-endemic areas); 2) parasites with variant-type
sequences did not differ morphologically from classic par-
asites; 3) variant-type parasites were present in both Asia
and Africa; and 4) parasites with variant-type sequences
tended to produce higher parasitemia levels and higher
proportions of single-species infection, when compared
with classic P. ovale infections acquired in the same region
(2,11). 
In contrast with P. falciparum and  P. vivax, little is
known about the patterns of genetic diversity in field iso-
lates of P. ovale. So far, full sequences of the SSUrRNA
gene have been analyzed for only three isolates, the
Nigerian I/CDC strain (6) and two African isolates,
Cameroon and MAL/MAI; partial sequences are also
available only for four isolates, the London School of
Hygiene and Tropical Medicine strain (LS train) and the
Nigerian I/CDC strain (13), and two isolates from Papua
New Guinea (14) and Ghana (C. Severini et al., unpub.
data). The cysteine protease gene was sequenced only for
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only source of available sequence for the cytochrome b
(cyt b) gene (16). More recently, two types of sequences
have been characterized for the ookinete surface protein
genes, Pos 25, Pos 28-1, and Pos 28-2 in P. ovale isolates
from Thailand (17,18). They correspond to the two types
of SSUrRNA genes, Nigerian I/CDC and LS, which sug-
gests that two sequence types might represent distinct vari-
ants or subspecies (13,18). 
We have obtained sequence data of the SSUrRNA, cys-
teine protease, ookinete surface protein, and cyt b genes of
P. ovale isolates from Myanmar and Indonesia and com-
pared our data with GenBank-available sequences. Our
analyses of both nuclear and mitochondrial genes provide
further support to the division of P. ovale into at least two
types. 
Materials and Methods
Field P. ovale Isolates 
All isolates were obtained during our recent field sur-
veys in Myanmar and Indonesia (2,11,12). For molecular
analysis of the variant and classic types, patients with sin-
gle infections were selected. The variant isolates we ana-
lyzed were ST243 (Rakhine State) and MC53 (Tanintharyi
Division), both from Myanmar, and M474 (Flores Island,
eastern Indonesia). The three classic isolates of M3 (Shan
State), M4 (Bago Division), and T134 (Mon State) were
collected from Myanmar.
Isolation of Parasite DNA and Confirmation 
of P. ovale by Sequence Analysis
Parasite DNA templates were isolated from blood by
using a DNA isolation Kit (High Pure PCR Template
Preparation Kit, Boehringer Mannheim, Germany). Then
the target sequences at the block 9 region used for PCR-
based diagnosis were further analyzed to confirm the pres-
ence of the variant- or classic-type in P. ovale–positive
samples. Amplified DNA products using the P1F-Up and
specific reverse (PoR2) primers (Table 1) underwent direct
sequencing, whereas the first PCR products were cloned
into the pCR II plasmid from a TACloning Kit (Invitrogen,
San Diego, CA). The target fragments of 12 positive
clones from each sample were sequenced by using Big
Dye Terminator sequencing kit on an ABI 310 sequencer
(PE Applied Biosystems, Foster City, CA).
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Table 1. Oligonucleotide primers used in this study 
Target gene  Primers  Sequences (5′→3′) 
A type of the SSUrRNA gene  18S F  AACCTGGTTGATCTTGCCAGTAGTC 
  18S F1  CGATTCGGAGAGGGAGCCTGA 
  PoR2  TGAAGGAAGCAATCTAAGAAATTT 
  P1F-UP  TCCATTAATCAAGAACGAAAGTTAAG 
  18S F2  TGGATGGTGATGCATGGCCGT 
  18S R  TAATGATCCTTCCGCAGGTTCACC 
Cytochrome b gene  Cyt b 1F  ATGAATTATTATTCTATTAATTTAG 
  Cyt b 1R  GGATCACTTACAGTATATCCTCC 
  Cyt b 2F  CAAATGAGTTATTGGGGTGCAAC 
  Cyt b 2R  TTTTAACATTGCATAAAATGGTA 
  Cyt b 3F  CCAAATCTATTAAGTCTTGATGT 
  Cyt b 3R  TGTTTGCTTGGGAGCTGTAATCA 
Cysteine protease gene  CysP-F  GCCAGTGTAGGTAATATTGAAT 
  CysP-R  GTATAAAATATCATCATCATCA 
Ookinete surface protein genes     
First polymerase chain reaction (PCR)     
Pos 25  Po8F2  CTTTTGTTAGTATTTCCTCC 
  Po8R1C  ACATTGAACACAGAATATGC 
Pos 28-1  Po1F1  TCCCCTTTTGTCCGTTTGTC 
  Po1R1  AAAGACTGCTACACGCATAC 
Pos 28-2  Po4NF1  GTTCATTACATTAAGTTCTC 
  Po4R1  TTAAATTGTATAAATTACACTG 
Nested PCR     
Pos 25  Po8F1-in  TTACAGTTTGTTTCTCGTC 
  Po8R1-in  AGGTTTAAGACATTGAACAC 
Pos 28-1  Po1F1-in  TTTTCTTTTCGTTTGCTTGC 
  Po1R1-in  TCAATATGGACACAGAATGC 
Pos 28-2  Po4F1-in  TTTACCATTTTCCAATATGC 
  Po4R1-in  CAATTAAAATTAAAATTCTG Analysis of SSUrRNA, Cysteine Protease, 
and cyt b Genes
Primer sets used were shown in Table 1. For analysis of
the SSUrRNA gene, PCR amplification was performed by
using AmpliTaq Gold polymerase (PE Applied
Biosystems) at 96°C for 10 min, 36 cycles at 94°C for 30
sec, 55°C for 1 min, and 72°C for 2 min, followed by one
cycle at 72°C for 10 min. 
For analysis of the cysteine protease and cyt b genes,
PCR conditions were slightly modified from the original
methods (15,16). The conditions used were one cycle at
96°C for 10 min, 36 cycles at 94°C for 30 s, 50°C for 1
min, and 72°C for 90 s, followed by one cycle at 72°C for
10 min. The amplified PCR products were cloned into the
pCR II vector. Plasmid DNA was purified from the posi-
tive colonies and sequenced in both directions by using the
primers described in Table 1 in combination with M13
primers. Sequencing was performed with an ABI 377
sequencer. Any ambiguity and putative polymorphism was
checked by additional amplification and sequencing.
Sequences obtained were compared with those reported in
databases. 
Gene sequences used for the SSUrRNA genes were
clone 9 and 26 of the Nigerian I/CDC strain (6), isolates
from Cameroon (8), MAL/MAI (X99790), Papua New
Guinea (14), Ghana (AJ250701), and two strains of the
Nigerian I/CDC and the London School of Hygiene and
Tropical Medicine (13). For the cysteine protease, P. ovale
Nigerian I/CDC, P. malariae WR314,  P. cynomolgi,  P.
reichenowi  (15),  P. vivax Salvador-1 (19), and P. falci-
parum (20) were used. For the cyt b. P. ovale Harding
strain, P. malariae Uganda-1, P. falciparum Kenya, Santa
Lucia, Malaysian-4, 3D7, P. simiovale,  P. knowlesi, P.
cynomolgi (16), P. falciparum Malay Camp (21) and C10
(22), P. reichenowi, P. falciparum NF54, K1, T9/96, 7G8
(23), Indian isolate 317 (24), P. vivax Salvador-I (25), and
Indian PH 10 (26) were retrieved as well as P. berghei (27)
and  P. yoelii (28). Dendrograms were obtained with
PHYLIP (Version 3.5c, University of Washington, Seattle,
WA) by using the neighbor-joining method with a
Kimura’s two-parameter distance and the maximum likeli-
hood method.
Sequence Analysis of Pos 25, 
Pos 28-1, and Pos 28-2 Genes
The procedures for first and nested PCR amplifications
with primers (Table 1) were described previously (17,18).
Nucleotide sequences were determined by direct sequenc-
ing with nested PCR products. Then, sequences obtained
were compared with those reported previously
(AB051631-3, AB074973-6).
Results
Sequence Analysis of the Full SSUrRNA Gene
Three different sequences were obtained for the
SSUrRNA gene from each variant-type isolate, while two
different sequences were detected from each classic-type
isolate (Figure 1). However, whether all of them were A
(asexual)-type genes or sequences included S (sexual)- or
O (ookinete/oocyst)-type (5,29,30) genes was unknown.
Hereafter, these sequences are referred to as Pov 1–3 for
the variant-type and as Poc 1–2 for the classic-type. 
The differences among Pov 1–3 were seen at the 5′ half
(Figure 1). When compared with the four complete
sequences in GenBank, the Cameroon and MAL/MAI iso-
lates were grouped as variant-type (>99% identity with
Pov 1–3 and <97% with Poc 1–2). Both African isolates
also shared the same mutation at the block 9 region
(nucleotide positions of 1158–1160). Particularly, the
sequence found in Cameroon isolate resembled that of Pov
1 (only 4-bp difference). 
The alignment of four partial sequences showed that,
despite their same origin, the partial sequence of the
Nigerian I/CDC (13) also showed 9-bp and 5-bp differ-
ences from those of clones 9 and 26, respectively. Among
these isolates, the LS strain possessed the same sequence
as the 3′ half of Pov 1–3, and thus it was grouped as vari-
ant type (<96% identity with Poc 1–2). The sequence of
the Papua New Guinea isolate was more similar to that of
clone 9 of the Nigerian I/CDC (≥98.8% identity with Poc
1 and <97% with Pov 1–3) than to that of clone 26 or Poc
2 (98.2%–98.4% identity). The Ghana isolate was also
grouped as classic-type (>97% identity with the Nigerian
I/CDC or Poc 1–2 and <92% with Pov 1–3). These results
suggest that the Papua New Guinea, Ghana, and our clas-
sic isolates are members of the classic- (Nigerian I/CDC-)
type group, whereas the Cameroon and MAL/MAI iso-
lates, as well as our variant isolates, are all members of the
variant- (LS-) type group. 
Sequence Analysis of the Cysteine Protease 
and the Ookinete Surface Protein Genes
The analysis of 531 bp of the cysteine protease genes,
when compared with the reported sequence of the Nigerian
I/CDC, showed that variant isolates differed at 19 bp
(3.6%) with eight nonsilent mutations and that classic-type
isolates had an almost identical sequence, except for a sin-
gle base at position 700 (nonsilent substitution from Pro to
Ala) (Table 2). Because the same substitution is also seen
in the variant P. ovale, P. falciparum, P. vivax, P. malariae,
P. reichenowi, and P. cynomolgi (data not shown), this
nucleotide may have been misread in the sequence of the
Nigerian I/CDC strain; if so, sequences of classic-type iso-
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the amino acid level, the variant isolates showed 96.0%
sequence identity with the classic isolates.
Tachibana et al. (17) have analyzed the ookinete sur-
face protein genes in Thai isolates and reported that two
(Nigerian I/CDC and LS) types of P. ovale, defined by the
SSUrRNA genes, have distinct sequences. Our nearly com-
plete sequences of Pos 25, Pos 28-1, and Pos 28-2 in vari-
ant isolates were identical to those found in LS-type Thai
isolates, while sequences in the classic isolates were iden-
tical to those of the Nigerian I/CDC-type (data not shown). 
Sequence Analysis of the cyt b Gene
The analysis of 1035 bp of the cyt b genes showed that
variant- and classic-type P. ovale isolates differed from
each other at 12 bp, with one nonsilent substitution
(Table 3). Sequences of variant isolates differed from those
reported for the Harding strain at 15 bp (1.4%), with two
nonsilent substitutions. The SSUrRNA gene of the Harding
strain was not reported yet, and whether this strain is of the
classic or variant type is not known. From its cyt b
sequence, it was expected that this strain may belong to
the classic group, despite the differences between the
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Figure 1. Different nucleotide sequences of the SSUrRNA genes among various Plasmodium ovale isolates. Numbers of nucleotides are
based on the P. ovale clone 9 sequence. Boldface letters show different nucleotides in each isolate. Poc 1–2 and Pov 1–3 indicate two
and three different sequences obtained from the classic and variant P. ovale isolates, respectively. Nigeria, Nigerian I/CDC strain; PNG,
Papua New Guinean isolate; LS, a strain from the London School of Hygiene and Tropical Medicine. Please see
www.cdc.gov/ncidod/eid/vol10no7/03-0411-G1.htm for a larger reproduction of this figure.
Table 2. Cysteine protease genes in different Plasmodium ovale isolates
a 
Position  444  471  501  552  599  600  633  685  700  720  774  786  789  860  881  886  895  896  914 
Nigerian 
I/CDC 
T  T  T  A  A  A  T  A  C  G  T  A  T  C  A  C  A  G  A 
Classic 
isolate 
T  T  T  A  A  A  T  A  G  G  T  A  T  C  A  C  A  G  A 
                  (P→A)                     
Variant 
isolate 
C  C  G  G  G  G  C  G  G  T  A  C  C  A  G  G  G  C  C 
          (K→R)    (N→D)  (P→A)          (T→K)  (K→R)  (H→D)  (S→A)  (E→A) 
aNucleotide numbers in boldface indicate positions resulting in nonsilent mutations (parentheses). respective sequences (3 bp, including one nonsynonymous
replacement). The dendrogram based on the cyt b genes
shown in Figure 2 suggests that P. ovale may be separated
into three types. A similar branching pattern was obtained
with the maximum likelihood method (data not shown).
However, some sequence mistakes cannot be ruled out in
GenBank-available sequences, such as that of Harding
strain (for example, nt 202–221 are conserved in all report-
ed Plasmodium spp. so far studied, except for P. ovale
Harding strain and P. malariae Uganda-1). As a result, it
seems more prudent to propose the separation of P. ovale
into only two types.
Discussion
By analyzing the 3′ half of the P. ovale SSUrRNA
genes, Li et al. (13) suggested that P. ovale might be sepa-
rated into two types or subspecies, Nigerian I/CDC and
LS. Later, the presence of LS-type or variant-type P. ovale
was confirmed in Vietnam (4) and Africa (7); all variant-
type isolates shared the same mutations at the block 9 in
the SSUrRNA gene. Sequence analyses of the ookinete sur-
face antigen gene, presented here and elsewhere (18), and
of the cysteine protease gene all confirmed the occurrence
of two different sequences in nuclear genes of parasites
grouped as variant type and Nigerian I/CDC or classic type
based on their SSUrRNA gene sequence. 
Whether the different sequences of SSUrRNA genes we
describe for classic-type and variant-type P. ovale isolates
correspond to A genes or include S or O genes is unclear
(5,29). In P. falciparum (30) and P. vivax (5), extensive
pairwise sequence diversity (>13% difference) has been
reported between A and S or O genes. In both classic type
and the variant isolates, however, SSUrRNA gene
sequences were quite similar to each other (<4% differ-
ence), which suggests that they may all correspond to A
genes. The occurrence of different A gene–like sequences
may be a distinctive feature of P. ovale, indicating a possi-
ble field for future research. 
Because of the strict sequence conservation of the mito-
chondrial cyt b gene in natural isolates of the human malar-
ia parasites P. falciparum and P. vivax, the divergence we
found between sequences from variant- and classic-type
parasites are putatively of major importance in defining
two genetically distinct types of P. ovale. Analyzing the
SSUrRNA gene of the Harding strain and determining
whether this strain belongs to the variant-type or classic-
type group or a third, poorly characterized group would be
of interest.
The prevalence and geographic distribution of P. ovale,
the last human malaria parasite to be described, have elicit-
ed little interest until recently. We have previously shown
that P. ovale is a widespread human pathogen in Southeast
Asia (1,2); here we suggest that, in both Southeast Asia
and Africa, at least two different types of P. ovale circulate
in human hosts. This situation is reminiscent of that recent-
ly described for P. vivax, which may be divided into two
types occurring respectively in the Old World and the New
World (31). However, both variants of P. ovale (in contrast
to those of P. vivax) occur in sympatry, which suggests that
the genetic differentiation between them is not associated
with geographic isolation. Moreover, the fact that human
infections with variant-type P. ovale tend to be associated
with higher levels of parasitemia, when compared with
levels associated with classic-type parasites (2,4,11), may
be the result of more dramatic biologic differences
between these types, with possible clinical implications.
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Table 3. cyt b genes in different Plasmodium ovale isolates
a 
Position  9  12  87  126  211  300  327  417  459  669  681  699  810  828  873 
Harding 
strain 
C  G  A  A  A  T  C  T  C  G  C  T  C  C  T 
Classic 
isolate 
T  A  A  A  G  T  C  T  C  G  C  T  C  C  T 
          (R→G)                     
Variant 
isolate 
T  A  C  G  G  A  T  A  T  T  T  A  T  T  A 
          (R→G)          (M→I)           
aNucleotide numbers in boldface indicate positions resulting in nonsilent mutations (parentheses). 
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